Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

[78] S. Bustin, V. Benes, J. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller,
T. Nolan, M. Pfaffl, G. Shipley, et al. The miqe guidelines: minimum information for
publication of quantitative real-time pcr experiments. Clinical chemistry, 55(4):611–
622, 2009.
[79] D. Cahill, K. Levine, R. Betensky, P. Codd, C. Romany, L. Reavie, T. Batchelor,
P. Futreal, M. Stratton, W. Curry, et al. Loss of the mismatch repair protein MSH6
in human glioblastomas is associated with tumor progression during temozolomide
treatment. Clinical cancer research, 13(7):2038, 2007.
[80] I. Camby, N. Nagy, M. Lopes, B. Schäfer, C. Maurage, M. Ruchoux, P. Murmann,
R. Pochet, C. Heizmann, J. Brotchi, et al. Supratentorial pilocytic astrocytomas,
astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential
expression of s100 proteins. Brain pathology, 9(1):1–19, 1999.
[81] M. Carlén, K. Meletis, C. Göritz, V. Darsalia, E. Evergren, K. Tanigaki, M. Amendola,
F. Barnabé-Heider, M. S. Y. Yeung, L. Naldini, T. Honjo, Z. Kokaia, O. Shupliakov,
R. M. Cassidy, O. Lindvall, and J. Frisén. Forebrain ependymal cells are Notchdependent
and generate neuroblasts and astrocytes after stroke. Nature neuroscience,
12(3):259–267, Mar. 2009.
[82] E. Carpenter, J. Goddard, A. Davis, T. Nguyen, and M. Capecchi. Targeted disruption
of hoxd-10 affects mouse hindlimb development. Development, 124(22):4505–4514,
1997.
[83] M. Carpenter, X. Cui, Z. Hu, J. Jackson, S. Sherman, Å. Seiger, and L. Wahlberg. In
vitro expansion of a multipotent population of human neural progenitor cells. Experimental
neurology, 158(2):265–278, 1999.
[84] A. Carracedo, A. Alimonti, and P. P. Pandolfi. PTEN Level in Tumor Suppression:
How Much Is Too Little? Cancer Research, 71(3):629–633, Feb. 2011.
[85] M. Carro, W. Lim, M. Alvarez, R. Bollo, X. Zhao, E. Snyder, E. Sulman, S. Anne,
F. Doetsch, H. Colman, et al. The transcriptional network for mesenchymal transformation
of brain tumours. Nature, 463(7279):318–325, 2009.
[86] E. Cerami, E. Demir, N. Schultz, and B. Taylor. Automated network analysis identifies
core pathways in glioblastoma. PLoS ONE, 2010.
[87] S. Certain, F. Barrat, E. Pastural, F. Le Deist, J. Goyo-Rivas, N. Jabado, M. Benkerrou,
R. Seger, E. Vilmer, G. Beullier, et al. Protein truncation test of lyst reveals
heterogenous mutations in patients with chediak-higashi syndrome. Blood, 95(3):979–
983, 2000.
[88] V. Chabottaux, S. Ricaud, L. Host, S. Blacher, A. Paye, M. Thiry, A. Garofalakis,
C. Pestourie, K. Gombert, F. Bruyere, et al. Membrane-type 4 matrix metalloproteinase
(mt4-mmp) induces lung metastasis by alteration of primary breast tumour
vascular architecture. Journal of cellular and molecular medicine, 13(9b):4002–4013,
2009.
[89] K. Chan, I. Espinosa, M. Chao, D. Wong, L. Ailles, M. Diehn, H. Gill, J. Presti,
H. Chang, M. Van De Rijn, et al. Identification, molecular characterization, clinical
prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings
of the National Academy of Sciences, 106(33):14016–14021, 2009.
[90] C. Cheadle, M. Nesterova, T. Watkins, K. Barnes, J. Hall, A. Rosen, K. Becker,
and Y. Cho-Chung. Regulatory subunits of pka define an axis of cellular proliferation/differentiation
in ovarian cancer cells. BMC Medical Genomics, 1(1):43, 2008.
[91] K. Chen and N. Rajewsky. Deep conservation of microRNA-target relationships and
3’UTR motifs in vertebrates, flies, and nematodes. Cold Spring Harb Symp Quant
Biol, 71:149–56, 2006.
[92] L. Z. L. Y. Z. Q. Chen K, Luo Z. Perp gene therapy attenuates lung cancer xenograft
via inducing apoptosis and suppressing vegf. Cancer biology and therapy, 12, 2011.
[93] A. J. S. T. S. C. B.-N. S. S. J. M. R. M. R. S. S. Q. H. P. J. T. A. R. T. L. W. S.
K. C. J. B. C. M. M. G. R. H. D. Cheung KâĂŘJJ, Johnson NA. Acquired tnfrsf14
mutations in follicular lymphoma are associated with worse prognosis. Cancer Res,
70:9166–9174, 2010.